COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 17:45, il y a 7 mois Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Disclosure of total voting rights and shares as of Jan 31, 2026 by Median Technologies. Cutting-edge AI for cancer diagnoses and treatments. Listed on Euronext Growth market Voting Rights Shares AI Median Technologies Cancer Diagnoses
COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 17:00, il y a 7 mois Mutares has completed the acquisition of Venator Ultramarine Blue Pigments business from Venator France SAS Mutares completes acquisition of Venator Ultramarine Blue Pigments business from Venator France SAS, strengthening Chemicals & Materials segment with strategic move into specialty chemicals industry Acquisition Specialty Chemicals Mutares Venator Chemicals & Materials
COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 16:40, il y a 7 mois Guidepoint Launches Guidepoint360 Mobile App, Delivering AI-Driven Research Whenever It's Needed Guidepoint launches Guidepoint360 mobile app, providing AI-driven research on-the-go. The app offers real-time expert intelligence for institutional investors, consulting firms, and enterprises, facilitating high-stakes decisions under tight timelines Mobile App AI-driven Research Guidepoint Guidepoint360 Expert Intelligence
COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 16:00, il y a 7 mois Eleving Group: the recording of 12M 2025 earnings call Eleving Group organized the 12M 2025 earnings call, presenting unaudited financial results and achievements, available for viewing. The company operates in 17 countries, offering financial services Financial Results Technology Earnings Call Eleving Group International Finance
COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 16:00, il y a 7 mois Information relative au nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2026 Arcure, spécialiste de l'intelligence artificielle pour l'industrie, coté sur Euronext Growth Paris (FR0013398997), présente son activité et ses résultats financiers Chiffre D'affaires Euronext Growth Intelligence Artificielle Arcure FR0013398997
COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 15:04, il y a 7 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% stake in JTC plc through 8,756,673 shares with a position date of 10 February 2026 The Vanguard Group Stake Disclosure 5.08% JTC Plc 8,756,673 Shares
COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 15:03, il y a 7 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.54% stake in Avadel Pharmaceuticals plc as of 10 Feb 2026. Form 8.3 filed with the Irish Takeover Panel Form 8.3 Irish Takeover Panel The Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 15:02, il y a 7 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 5.03% ownership in Beazley plc as of 10-Feb-2026 Relevant Securities The Vanguard Group Ownership Disclosure Financial Disclosure Beazley Plc
COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 14:59, il y a 7 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.60% stake in Spire Healthcare Group plc. Public disclosure under Rule 8.3 of the Takeover Code on 11 Feb 2026 Rule 8.3 Vanguard Group Inc. Takeover Code Stake Disclosure Spire Healthcare Group Plc
COMMUNIQUÉ DE PRESSE publié le 11/02/2026 à 14:58, il y a 7 mois 1 jour Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 4.93% ownership in Just Group plc in a Form 8.3 filing. Public position disclosure under Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Ownership Disclosure Just Group Plc
Publié le 11/09/2026 à 07:00, il y a 1 jour 8 heures BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Publié le 11/09/2026 à 07:00, il y a 1 jour 8 heures BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Publié le 10/09/2026 à 19:30, il y a 1 jour 20 heures Availability of the 2026 Interim Financial Report
Publié le 12/09/2026 à 02:35, il y a 13 heures 24 minutes Gamma Resources Announces Extension of Private Placement Closing Date
Publié le 11/09/2026 à 23:00, il y a 16 heures 59 minutes Rio Grande Resources Engages Machai Capital for Investor Outreach
Publié le 11/09/2026 à 22:05, il y a 17 heures 54 minutes Usha Resources Announces Leadership Transition
Publié le 11/09/2026 à 21:25, il y a 18 heures 34 minutes Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Publié le 11/09/2026 à 17:00, il y a 22 heures 59 minutes Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Publié le 12/09/2026 à 07:30, il y a 8 heures 28 minutes NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Publié le 11/09/2026 à 22:15, il y a 17 heures 43 minutes Amrize Appoints Mario Gross as President of Building Envelope
Publié le 11/09/2026 à 22:10, il y a 17 heures 48 minutes Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Publié le 11/09/2026 à 19:44, il y a 20 heures 14 minutes DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Publié le 11/09/2026 à 18:15, il y a 21 heures 43 minutes CGTN: How BRICS creates new opportunities for Global South development